Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the ...
Biogen (BIIB) and Stoke Therapeutics (STOK) announced the presentation of longer-term follow-up analyses from the ongoing open-label extension ...
Stoke Therapeutics (STOK) and Biogen (BIIB) announced the presentation of longer-term follow-up analyses from the ongoing open-label extension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback